Genetically overexpressing TGFβ spontaneously induce liver fibrosis, whereas genetic deletion or pharmacological blockade of TGFβ could ameliorate fibrosis in mice (Hellerbrand et al., 1999; de Gouville et al., 2005). This evidence concerns the gene TGFB1 and Hepatic fibrosis.